Sidella, Letizia
 Distribuzione geografica
Continente #
EU - Europa 345
NA - Nord America 264
AS - Asia 81
SA - Sud America 16
Totale 706
Nazione #
US - Stati Uniti d'America 248
DE - Germania 151
PL - Polonia 36
CN - Cina 35
SE - Svezia 35
UA - Ucraina 33
FR - Francia 32
SG - Singapore 27
IT - Italia 19
BR - Brasile 15
GB - Regno Unito 14
CA - Canada 13
IE - Irlanda 8
FI - Finlandia 6
ID - Indonesia 6
IN - India 6
TR - Turchia 5
RU - Federazione Russa 4
CH - Svizzera 3
BE - Belgio 2
KR - Corea 2
AR - Argentina 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
MX - Messico 1
NL - Olanda 1
Totale 706
Città #
Chandler 42
Kraków 36
Ashburn 27
Jacksonville 19
San Mateo 16
Singapore 16
Ottawa 13
Wilmington 13
Ann Arbor 12
Cattolica 12
Woodbridge 12
Nürnberg 11
Nanjing 9
Dublin 8
New York 7
Chicago 6
Dearborn 6
Jakarta 6
Lawrence 6
Izmir 5
Bremen 4
Fremont 4
Hebei 4
Redmond 4
Redwood City 4
Boston 3
Falls Church 3
Houston 3
Kunming 3
Los Angeles 3
Munich 3
Nanchang 3
Seattle 3
Auburn Hills 2
Augusta 2
Bari 2
Brussels 2
Guangzhou 2
Lanzhou 2
Milan 2
Moscow 2
University Park 2
Acrelândia 1
Amsterdam 1
Aparecida de Goiânia 1
Bern 1
Busto Arsizio 1
Cambridge 1
Campos dos Goytacazes 1
Changchun 1
Changsha 1
Cheboksary 1
Criciúma 1
Edinburgh 1
El Factor 1
Fairfield 1
Fuzhou 1
Hefei 1
Itapecerica da Serra 1
Jinan 1
Juiz de Fora 1
Lancaster 1
Leawood 1
London 1
Mafra 1
Manaus 1
Marseille 1
Mountain View 1
Ningbo 1
Olomouc 1
Osasco 1
Raleigh 1
Rio de Janeiro 1
San Pedro Sula 1
Santa Maria da Vitória 1
Secunderabad 1
Serrinha 1
São Paulo 1
Tenente Portela 1
Umuarama 1
Viedma 1
Washington 1
Zhengzhou 1
Totale 385
Nome #
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 225
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 152
HIV-infected patients show impaired cellular immune response to influenza vaccination, compared to healthy subjects 98
HIV-infected patients show impaired cellular immune response to influenza vaccination compared to healthy subjects 93
Lipid-lowering effect of tenofovir in HIV-infected patients 80
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy 58
Totale 706
Categoria #
all - tutte 2.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 8 4 14 5 9 5 6
2020/202171 2 11 1 8 7 5 10 2 11 3 11 0
2021/202252 5 7 0 3 5 3 1 13 1 1 10 3
2022/2023105 15 17 9 13 9 16 2 6 14 0 3 1
2023/202454 2 13 2 8 1 14 0 0 1 0 10 3
2024/202554 1 3 6 7 26 11 0 0 0 0 0 0
Totale 706